Skip to main content
Menu
Developmental BioEngineering (DBE)
UT
Faculties
TNW
Research
Dept BET
DBE
News & Events
Hy2Care® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant
Developmental BioEngineering (DBE)
UT
Faculties
TNW
Research
Dept BET
DBE
News & Events
Hy2Care® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant
Hy2Care® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant
.
Previous article
Next article
Monday 26 May 2025
Hy2CareĀ® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant
Press here for online English version:
Hy2Care® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant
Hier openen voor online Nederlandse versie:
Hy2Care® received FDA IDE approval to launch U.S. clinical trial for cartilage repair implant
More recent news
Mon 26 May 2025
Hy2Care® secures €4.5 million in funding to prepare for U.S. clinical trial and commercial expansion
Fri 23 May 2025
INTELLECTUALS Program
Fri 13 Jan 2023
Marcel Karperien in Koffietijd
Tue 13 Dec 2022
Artrose blijkt wel degelijk te behandelen: met speciale gel.
Thu 16 Jun 2022
DBE participates in COST proposal building an open European Network on OsteoArthritis financed by the EU
News summary
Close
Suggestions